Skip to main navigation Skip to search Skip to main content

Successful management of rocuronium-induced anaphylactic reactions with sugammadex: A case report

  • Takashi Kawano
  • , Takahiko Tamura
  • , Mayuko Hamaguchi
  • , Tomoaki Yatabe
  • , Koichi Yamashita
  • , Masataka Yokoyama

    Research output: Contribution to journal › Article › peer-review

    Abstract

    Sugammadex, a new reversal agent for rocuronium, encapsulates the rocuronium molecule and results in rapid reversal of rocuronium-induced neuromuscular blockade. A case in which sugammadex was used to treat an anaphylactic reaction that occurred after rocuronium is presented. The binding/encapsulation of rocuronium by sugammadex may selectively eliminate the antigenic quaternary ammonium activity of circulating rocuronium, and prevent the propagation of rocuronium-induced anaphylaxis.

    Original languageEnglish
    Pages (from-to)62-64
    Number of pages3
    JournalJournal of Clinical Anesthesia
    Volume24
    Issue number1
    DOIs
    Publication statusPublished - 02-2012

    All Science Journal Classification (ASJC) codes

    • Anesthesiology and Pain Medicine

    Fingerprint

    Dive into the research topics of 'Successful management of rocuronium-induced anaphylactic reactions with sugammadex: A case report'. Together they form a unique fingerprint.

    Cite this